Amgen Newsroom

Jefferies Maintains Amgen(AMGN.US) With Buy Rating, Cuts Target Price to $350

Moomoo NewsDec 20 13:39 ET

Jefferies Adjusts Amgen Price Target to $350 From $380, Maintains Buy Rating

MT NewswiresDec 19 11:53 ET

UBS Cuts Price Target on Amgen to $280 From $326, Maintains Neutral Rating

MT NewswiresDec 17 09:32 ET

Oppenheimer Maintains Amgen(AMGN.US) With Buy Rating, Maintains Target Price $380

Moomoo NewsDec 11 08:31 ET

Oppenheimer Remains a Buy on Amgen (AMGN)

TipRanksDec 11 07:52 ET

Amgen Analyst Ratings

BenzingaDec 10 07:29 ET

Evercore Maintains Amgen(AMGN.US) With Buy Rating

Moomoo NewsDec 2 08:31 ET

TD Cowen Maintains Amgen(AMGN.US) With Buy Rating, Maintains Target Price $383

Moomoo NewsDec 2 07:32 ET

TD Cowen Reaffirms Their Buy Rating on Amgen (AMGN)

TipRanksDec 2 07:27 ET

RBC Capital Maintains Amgen(AMGN.US) With Buy Rating, Cuts Target Price to $360

Moomoo NewsNov 28 19:31 ET

Amgen Analyst Ratings

BenzingaNov 27 12:03 ET

RBC Capital Maintains Outperform on Amgen, Lowers Price Target to $330

BenzingaNov 27 12:03 ET

BMO Capital Maintains Amgen(AMGN.US) With Buy Rating, Maintains Target Price $362

Moomoo NewsNov 27 08:35 ET

TD Cowen Maintains Amgen(AMGN.US) With Buy Rating, Maintains Target Price $383

Moomoo NewsNov 27 08:34 ET

Truist Financial Maintains Amgen(AMGN.US) With Hold Rating

Moomoo NewsNov 27 08:34 ET

A Quick Look at Today's Ratings for Amgen(AMGN.US), With a Forecast Between $305 to $380

Moomoo NewsNov 27 08:02 ET

Deutsche Bank Adjusts Price Target on Amgen to $285 From $305, Maintains Hold Rating

MT NewswiresNov 27 06:12 ET

Amgen's MariTide Phase 2 Success Drives Buy Rating Amid Promising Obesity Treatment Prospects

TipRanksNov 27 02:35 ET

Citigroup Adjusts Price Target on Amgen to $310 From $335, Neutral Rating Maintained

MT NewswiresNov 26 08:33 ET

The Trader: Eli Lilly and 2 More Drug Stocks to Buy After RFK-Inspired Drop -- Barron's

Barron'sNov 22 21:30 ET